Alendronate sodium and Macitentan drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Alendronate sodium (alendronate sodium) and Macitentan (macitentan). Common drug interactions include epistaxis among females and cardiac failure among males.
The phase IV clinical study analyzes what interactions people have when they take Alendronate sodium and Macitentan. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.
What is Alendronate sodium?
Alendronate sodium has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 43,608 Alendronate sodium users. Check the latest studies of Alendronate sodium.
What is Macitentan?
Macitentan has active ingredients of macitentan. eHealthMe is studying from 7,371 Macitentan users. Check the latest studies of Macitentan.
18 people who take Alendronate sodium and Macitentan together, and have interactions are studied.

What are the common drug interactions of Alendronate Sodium and Macitentan, by gender? *:
female:
- Epistaxis (bleed from the nose)
- Haemorrhage (bleeding)
- Headache (pain in head)
- Hot flush (sudden feelings of heat)
- Malaise (a feeling of general discomfort or uneasiness)
- Oedema peripheral (superficial swelling)
- Oxygen saturation decreased
- Platelet count decreased
- Pneumonia
- Pyrexia (fever)
male:
- Cardiac failure
- Respiratory failure (inadequate gas exchange by the respiratory system)
What are the common drug interactions of Alendronate Sodium and Macitentan, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Diarrhoea
- Vomiting
- Haemorrhage (bleeding)
- Headache (pain in head)
- Hot flush (sudden feelings of heat)
- Malaise (a feeling of general discomfort or uneasiness)
- Oedema peripheral (superficial swelling)
- Oxygen saturation decreased
- Platelet count decreased
- Pneumonia
What are the existing conditions these people have? *
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 14 people, 77.78%
- Iron Deficiency Anaemia: 8 people, 44.44%
- Connective Tissue Disorder (any disease that has the connective tissues of the body): 6 people, 33.33%
- Depression: 6 people, 33.33%
- Hypokalemia (low potassium): 6 people, 33.33%
- Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 6 people, 33.33%
- Right Ventricular Failure (right half of the heart fails to work): 6 people, 33.33%
- Salivary Gland Calculus (stone in salivary gland): 5 people, 27.78%
- Sedation: 4 people, 22.22%
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 4 people, 22.22%
* Approximation only. Some reports may have incomplete information.
Do you take Alendronate sodium and Macitentan?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Alendronate sodium (43,608 reports)
- Macitentan (7,371 reports)
Browse all drug interactions of Alendronate sodium and Macitentan:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Alendronate sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Macitentan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Alendronate sodium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Macitentan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Stuckey BG, Sallie R, "Alendronate-induced unmasking or deterioration of coeliac disease: a case series", Osteoporosis International, 2015 Jan .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
- Stuckey BG, Sallie R, "Alendronate-induced unmasking or deterioration of coeliac disease: a case series", Osteoporosis International, 2015 Jan .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on alendronate sodium and macitentan (the active ingredients of Alendronate sodium and Macitentan, respectively), and Alendronate sodium and Macitentan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Telmisartan cause Hepatic Failure? - 2 seconds ago
- Could Cosentyx cause Haemorrhage Urinary Tract? - 4 seconds ago
- Could Viibryd cause Hypercholesterolaemia Aggravated? - 18 seconds ago
- Drug interactions of Duloxetine Hydrochloride and Haloperidol - 48 seconds ago
- Drug interactions of Palonosetron and Clotrimazole - 51 seconds ago
- Drug interactions of Elavil and Sutent - 55 seconds ago
- Could Catapres cause Insomnia? - 57 seconds ago
- Could Wellbutrin cause Lip Dry? - a minute ago
- Could Hizentra cause Infusion Site Pain? - a minute ago
- How effective is Gabapentin for Complex Regional Pain Syndrome? - a minute ago